Review
Published on 08 Nov 2024
The role of neutrophils in osteosarcoma: insights from laboratory to clinic
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1490712
- 253 views
Type at least 3 characters
6,667 articles
Articles
Original Research
Published on 08 Nov 2024
GPER1 signaling restricts macrophage proliferation and accumulation in human hepatocellular carcinoma
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1481972
- 325 views
Review
Published on 08 Nov 2024
Models of fibrolamellar carcinomas, tools for evaluation of a new era of treatments
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1459942
- 300 views
Systematic Review
Accepted on 07 Nov 2024
The load of hepatitis B virus reduces the immune checkpoint inhibitors efficiency in hepatocellular carcinoma patients
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1480520
- 133 views
Original Research
Accepted on 07 Nov 2024
Mid-term follow-up results of neoadjuvant sintilimab combined with chemotherapy for locally advanced resectable esophageal squamous cell carcinoma
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1453176
Original Research
Accepted on 07 Nov 2024
ID1 and ID3 functions in the modulation of the tumour immune microenvironment in Adult Patients with B-Cell Acute Lymphoblastic Leukaemia
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1473909
Original Research
Published on 07 Nov 2024
Invention and characterization of a systemically administered, attenuated and killed bacteria-based multiple immune receptor agonist for anti-tumor immunotherapy
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1462221
- 513 views
Perspective
Published on 07 Nov 2024
Identifying optimal tumor-associated antigen combinations with single-cell genomics to enable multi-targeting therapies
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1492782
- 763 views
Original Research
Published on 07 Nov 2024
Clinically relevant body composition phenotypes are associated with distinct circulating cytokine and metabolomic milieus in epithelial ovarian cancer patients
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1419257
- 601 views
Original Research
Published on 07 Nov 2024
Depicting the cellular complexity of pancreatic adenocarcinoma by Imaging Mass Cytometry: focus on cancer-associated fibroblasts
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1472433
- 997 views
Original Research
Published on 07 Nov 2024
Human CD34+-derived plasmacytoid dendritic cells as surrogates for primary pDCs and potential cancer immunotherapy
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1433119
- 539 views
Original Research
Published on 07 Nov 2024
Integrated analysis of single-cell, spatial and bulk RNA-sequencing identifies a cell-death signature for predicting the outcomes of head and neck cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1487966
- 647 views
Correction
Published on 07 Nov 2024
Corrigendum: Causal pathways in lymphoid leukemia: the gut microbiota, immune cells, and serum metabolites
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1498574
- 217 views
Systematic Review
Published on 07 Nov 2024
Impact of bone metastasis on prognosis in non-small cell lung cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1493773
- 433 views
Review
Published on 07 Nov 2024
Research progress of CD80 in the development of immunotherapy drugs
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1496992
- 329 views
Original Research
Published on 07 Nov 2024
Immunotherapy plus chemotherapy versus chemotherapy alone in the first-line treatment for advanced gastric cancer/gastroesophageal junction cancer: a real-world retrospective study
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1463017
- 567 views